Etelcalcetide Effective in Cases Where Cinacalcet Is Problematic
Switching from oral to intravenous calcimimetic may lower PTH levels in patients on hemodialysis with poor tolerance.
Switching from oral to intravenous calcimimetic may lower PTH levels in patients on hemodialysis with poor tolerance.
Researchers studied whether skeletal muscle mass measurments could predict bone mineral density change following parathyroidectomy.
Osteoporosis can be related to primary hyperparathyroidism (PHPT) in older adults. Researchers studied fracture rates in people with and without parathyroidectomy.
Investigators studied whether primary hyperparathyroidism is associated with arrhythmia or other cardiac conduction abnormalities as shown on electrocardiogram.
Anxiety and depression in people with hyperparathyroidism may be related to levels of 2 key hormones in the body, according to researchers.
Patients on hemodialysis who have secondary hyperparathyroidism experienced a 40% reduction in PTH levels over 12 months of etelcalcetide treatment, investigators reported.
Weight loss partly accounted for the association between high parathyroid hormone levels and mortality among patients on hemodialysis.
Etelcalcetide use in patients with diabetic nephropathy might protect against development of adynamic bone disease, according to investigators.
In a large, single-center study, severe hypocalcemia developed in 1 in 4 patients who underwent total parathyroidectomy without autotransplantation.
A recently published report describes the case of a 61-year-old male patient who experienced antacid-induced hypercalcemia and highlights the importance of performing thorough medication reconciliation.